Institutional portfolio tracker

Third Point Portfolio & AI Predictions

Explore Third Point's latest validated 13F portfolio and Hallucination Yield AI forecasts for covered positions.

Form 13F reports holdings as of 2026-03-31 and was filed on 2026-05-15. It is delayed, can omit confidential positions, and is not the manager's current portfolio or fund NAV. Options show reported underlying value—not premium, net exposure, or investment intent.

Disclosed long book

$1.87 billion

Long positions

33

Calls / puts

0 / 0

Top 5 concentration

57.4%

Longs with AI data

9 / 33

Average AI 1Y

+20.5%

Monitored between quarterly reports

Beneficial-ownership disclosures

Schedules 13D and 13G can reveal a significant ownership event after a quarter closes. They are shown as a separate event timeline and never folded back into the 2026-03-31 Form 13F portfolio.

Third Point Private Capital Partners

SCHEDULE 13DPost-quarter event

The filing reports Third Point LLC's beneficial ownership as of April 7, 2026: 1,601,000 shares or share-equivalents representing 76.6% of the reported class. It was filed on April 14, 2026.

Calculations of the percentage of Class I Common Shares beneficially owned assumes 2,089,463 shares of Class I Common Shares outstanding as disclosed by the Issuer.

Official SEC disclosure ↗

flyExclusive, Inc.

SCHEDULE 13D/ASeparate ownership event

The filing reports Third Point LLC's beneficial ownership as of January 9, 2026: 1,389,499 shares or share-equivalents representing 4.4% of the reported class. It was filed on January 13, 2026.

The number of shares of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock") of flyExclusive, Inc. (the "Issuer") beneficially owned by the Reporting Persons as set forth in Row 11 (such shares, the "Shares") consists of 1,022,000 shares of Class A Common Stock and 367,499 shares of Class A Common Stock issuable upon the exercise of warrants of the Issuer. Calculations of the percentage set forth in Row 13 are based on the quotient obtained by dividing (a) the aggregate number of Shares by (b) the sum of (i) 31,184,738 shares of Class A Common Stock outstanding as of

Official SEC disclosure ↗

Strata Critical Medical, Inc.

SCHEDULE 13G/ASeparate ownership event

The filing reports Third Point LLC's beneficial ownership as of September 30, 2025: 5,000,000 shares or share-equivalents representing 5.8% of the reported class. It was filed on November 14, 2025.

Calculation of the percentage set forth in Row 11 is based on the quotient obtained by dividing (a) the number of shares of Common Stock, $0.0001 par value per share ("Common Stock"), of Strata Critical Medical, Inc. (the "Issuer") beneficially owned by the Reporting Persons as set forth in Row 9 by (b) the 86,366,526 shares of Common Stock outstanding as of November 3, 2025, as reported by the Issuer in its quarterly report on Form 10-Q for the fiscal quarter ended September 30, 2025, as filed with the U.S. Securities and Exchange Commission on November 10, 2025.

Official SEC disclosure ↗

Soho House & Co Inc.

SCHEDULE 13D/ASeparate ownership event

The filing reports Third Point LLC's beneficial ownership as of August 18, 2025: 0 shares or share-equivalents representing 0% of the reported class. It was filed on August 20, 2025.

Official SEC disclosure ↗

Blade Air Mobility, Inc.

SCHEDULE 13GSeparate ownership event

The filing reports Third Point LLC's beneficial ownership as of August 4, 2025: 5,000,000 shares or share-equivalents representing 6.1% of the reported class. It was filed on August 11, 2025.

Calculation of the percentage set forth in Row 11 is based on the quotient obtained by dividing (a) the number of shares of Common Stock, $0.0001 par value per share ("Common Stock"), of Blade Air Mobility, Inc. (the "Issuer") beneficially owned by the Reporting Persons as set forth in Row 9 by (b) the 81,695,605 shares of Common Stock outstanding as of July 29, 2025, as reported by the Issuer in its quarterly report on Form 10-Q for the fiscal quarter ended June 30, 2025, as filed with the U.S. Securities and Exchange Commission on August 5, 2025.

Official SEC disclosure ↗

UNITED STATES STEEL CORP

SCHEDULE 13GSeparate ownership event

The filing reports Third Point LLC's beneficial ownership as of April 30, 2025: 12,250,000 shares or share-equivalents representing 5.4% of the reported class. It was filed on May 7, 2025.

The number of shares of United States Steel Corporation Common Stock (the "Common Stock") of United States Steel Corporation (the "Issuer") beneficially owned by the Reporting Persons as set forth in Row 9 (such shares, the "Shares") consists of 11,250,000 shares of Common Stock and 1,000,000 shares of Common Stock underlying call options. Calculations of the percentage set forth in Row 11 are based on the quotient obtained by dividing (a) the aggregate number of Shares by (b) the 226,419,128 shares of Common Stock outstanding as of April 28, 2025, as reported in the Issuer's quarterly report

Official SEC disclosure ↗

flyExclusive, Inc.

SCHEDULE 13D/ASeparate ownership event

The filing reports Third Point LLC's beneficial ownership as of March 24, 2025: 1,389,499 shares or share-equivalents representing 6.8% of the reported class. It was filed on March 26, 2025.

The number of shares of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock") of flyExclusive, Inc. (the "Issuer") beneficially owned by the Reporting Persons as set forth in Row 11 (such shares, the "Shares") consists of 1,022,000 shares of Class A Common Stock and 367,499 shares of Class A Common Stock issuable upon the exercise of warrants of the Issuer. Calculations of the percentage set forth in Row 13 are based on the quotient obtained by dividing (a) the aggregate number of Shares by (b) the sum of (i) 20,199,586 shares of Class A Common Stock outstanding as of

Official SEC disclosure ↗

Cinemark Holdings, Inc.

SCHEDULE 13G/ASeparate ownership event

The filing reports Third Point LLC's beneficial ownership as of December 31, 2024: 3,750,000 shares or share-equivalents representing 3.1% of the reported class. It was filed on February 14, 2025.

Official SEC disclosure ↗

Soho House & Co Inc.

SCHEDULE 13DSeparate ownership event

The filing reports Third Point LLC's beneficial ownership as of January 22, 2025: 5,200,000 shares or share-equivalents representing 9.89% of the reported class. It was filed on January 29, 2025.

Calculations of the percentage of Common Stock beneficially owned assumes 52,560,469 shares of Common Stock outstanding as reported in the Issuer's Quarterly Report on Form 10-Q filed on December 20, 2024.

Official SEC disclosure ↗

Telephone and Data Systems, Inc.

SCHEDULE 13GSeparate ownership event

The filing reports Third Point LLC's beneficial ownership as of December 17, 2024: 6,000,000 shares or share-equivalents representing 5.7% of the reported class. It was filed on December 26, 2024.

Official SEC disclosure ↗
PositionKindSharesValueLong weightQuarter changeAI at filing · 1YAI now

AMZN

AMAZON COM INC · COM · 023135106

LONG 1,940,000 $404.0 million 21.6% REDUCED

1Y +19.2%

5Y +115.8% · 6 models

TELEPHONE & DATA SYS INC

TELEPHONE & DATA SYS INC · COM NEW · 879433829

LONG 6,600,000 $277.9 million 14.8% REDUCED

1Y —

5Y —

CRH PLC

CRH PLC · ORD · G25508105

LONG 1,900,000 $199.7 million REDUCED

1Y —

5Y —

SOMNIGROUP INTERNATIONAL INC

SOMNIGROUP INTERNATIONAL INC · COM · 88023U101

LONG 2,270,769 $167.9 million 9.0% REDUCED

1Y —

5Y —

CARPENTER TECHNOLOGY CORP

CARPENTER TECHNOLOGY CORP · COM · 144285103

LONG 310,000 $122.2 million 6.5% REDUCED

1Y —

5Y —

MTZ

MASTEC INC · COM · 576323109

LONG 320,000 $103.0 million 5.5% REDUCED

1Y +18.2%

5Y +86.0% · 5 models

DANAHER CORPORATION

DANAHER CORPORATION · COM · 235851102

LONG 525,000 $99.5 million 5.3% REDUCED

1Y —

5Y —

TSM

TAIWAN SEMICONDUCTOR MANUFAC · SPONSORED ADS · 874039100

LONG 275,000 $92.9 million 5.0% REDUCED

1Y +23.6%

5Y +131.0% · 5 models

API GROUP CORP

API GROUP CORP · COM STK · 00187Y100

LONG 2,030,000 $82.3 million 4.4% REDUCED

1Y —

5Y —

LIVE NATION ENTERTAINMENT IN

LIVE NATION ENTERTAINMENT IN · COM · 538034109

LONG 465,000 $70.9 million 3.8% REDUCED

1Y —

5Y —

META

META PLATFORMS INC · CL A · 30303M102

LONG 90,000 $51.5 million 2.7% NEWLY REPORTED

1Y +18.8%

5Y +116.7% · 6 models

GOOGL

ALPHABET INC · CAP STK CL A · 02079K305

LONG 175,000 $50.3 million 2.7% NEWLY REPORTED

1Y +15.8%

5Y +98.3% · 6 models

SPDR GOLD TR

SPDR GOLD TR · GOLD SHS · 78463V107

LONG 95,000 $40.9 million 2.2% NEWLY REPORTED

1Y —

5Y —

HUT 8 CORP

HUT 8 CORP · COM · 44812J104

LONG 869,563 $40.8 million 2.2% NEWLY REPORTED

1Y —

5Y —

NVDA

NVIDIA CORPORATION · COM · 67066G104

LONG 190,000 $33.1 million 1.8% REDUCED

1Y +24.8%

5Y +167.5% · 6 models

TRANSDIGM GROUP INC

TRANSDIGM GROUP INC · COM · 893641100

LONG 25,000 $29.0 million 1.5% NEWLY REPORTED

1Y —

5Y —

NORFOLK SOUTHERN CORP

NORFOLK SOUTHERN CORP · COM · 655844108

LONG 100,000 $28.7 million 1.5% REDUCED

1Y —

5Y —

CAPITAL ONE FINL CORP

CAPITAL ONE FINL CORP · COM · 14040H105

LONG 140,000 $25.5 million 1.4% REDUCED

1Y —

5Y —

UNION PAC CORP

UNION PAC CORP · COM · 907818108

LONG 100,000 $24.3 million 1.3% REDUCED

1Y —

5Y —

STRATA CRITICAL MEDICAL INC

STRATA CRITICAL MEDICAL INC · CL A COM · 092667104

LONG 5,000,000 $20.9 million 1.1% UNCHANGED

1Y —

5Y —

KLA CORP

KLA CORP · COM NEW · 482480100

LONG 11,000 $16.2 million 0.9% NEWLY REPORTED

1Y —

5Y —

LRCX

LAM RESEARCH CORP · COM NEW · 512807306

LONG 75,000 $16.0 million 0.9% NEWLY REPORTED

1Y +20.6%

5Y +126.0% · 5 models

ASML

ASML HLDG NV · N Y REGISTRY SHS · N07059210

LONG 12,000 $15.8 million 0.8% NEWLY REPORTED

1Y +19.5%

5Y +114.2% · 6 models

AVGO

BROADCOM INC · COM · 11135F101

LONG 50,000 $15.5 million 0.8% NEWLY REPORTED

1Y +23.5%

5Y +135.8% · 6 models

SMH

VANECK ETF TRUST · SEMICONDUCTR ETF · 92189F676

LONG 40,000 $15.3 million 0.8% NEWLY REPORTED

1Y —

5Y —

SHARKNINJA INC

SHARKNINJA INC · COM SHS · G8068L108

LONG 130,509 $13.8 million 0.7% REDUCED

1Y —

5Y —

HTZWW

HERTZ GLOBAL HLDGS INC · *W EXP 06/30/205 · 42806J148

LONG 3,970,000 $9.1 million UNCHANGED

1Y —

5Y —

ARS PHARMACEUTICALS INC

ARS PHARMACEUTICALS INC · COM · 82835W108

LONG 1,000,000 $8.0 million 0.4% INCREASED

1Y —

5Y —

AURORA INNOVATION INC

AURORA INNOVATION INC · CLASS A COM · 051774107

LONG 1,032,463 $4.3 million 0.2% UNCHANGED

1Y —

5Y —

FLYEXCLUSIVE INC

FLYEXCLUSIVE INC · COM CL A · 343928107

LONG 1,022,000 $2.3 million 0.1% UNCHANGED

1Y —

5Y —

CLARITEV CORPORATION

CLARITEV CORPORATION · CL A NEW · 62548M209

LONG 44,000 $718,960 0.0% REDUCED

1Y —

5Y —

AURORA INNOVATION INC

AURORA INNOVATION INC · *W EXP 11/03/202 · 051774115

LONG 1,835,000 $365,165 UNCHANGED

1Y —

5Y —

FLYEXCLUSIVE INC

FLYEXCLUSIVE INC · *W EXP 99/99/999 · 343928115

LONG 367,499 $88,200 UNCHANGED

1Y —

5Y —

AI outlook values are averages across the latest successful run per covered model at the labeled cutoff. “No longer reported” does not necessarily mean sold; thresholds, confidential treatment, corporate actions, or instrument changes may explain an omission. Reviewed API mapping covers 0.0% of disclosed long-book value; exact editorial CUSIP mappings may add current-only AI coverage on this public page. Research use only. No warranty and not investment advice.

Filing history

Get filing alerts →

Every filing event remains separate, including notices and amendments. Open a holdings date for the canonical portfolio through its latest filing, or an accession for the exact source event.

Holdings dateFiledFormProcessingAccession
2026-03-31 2026-05-15 13F-HR VALIDATED 0001040273-26-000002
2025-12-31 2026-02-17 13F-HR VALIDATED 0001040273-26-000001
2025-09-30 2025-11-14 13F-HR VALIDATED 0001040273-25-000003
2025-06-30 2025-08-14 13F-HR VALIDATED 0001085146-25-005277
2025-03-31 2025-05-15 13F-HR VALIDATED 0001085146-25-003337
2024-12-31 2025-02-14 13F-HR VALIDATED 0001085146-25-001713
2024-09-30 2024-11-14 13F-HR VALIDATED 0001085146-24-005927
2024-06-30 2024-08-14 13F-HR VALIDATED 0001085146-24-004004
2024-03-31 2024-05-15 13F-HR VALIDATED 0001085146-24-002645
2023-12-31 2024-02-14 13F-HR VALIDATED 0001085146-24-001503
2023-09-30 2023-11-14 13F-HR VALIDATED 0001085146-23-004511
2023-06-30 2023-08-14 13F-HR VALIDATED 0001085146-23-003432
2023-03-31 2023-05-15 13F-HR VALIDATED 0001085146-23-002451
2022-12-31 2023-02-14 13F-HR VALIDATED 0001085146-23-001325
2022-09-30 2022-11-14 13F-HR VALIDATED 0001085146-22-004128
2022-06-30 2022-08-15 13F-HR VALIDATED 0001085146-22-003130
2022-03-31 2022-05-16 13F-HR VALIDATED 0001085146-22-002202
2021-12-31 2022-02-14 13F-HR VALIDATED 0001085146-22-001108
2021-09-30 2021-11-15 13F-HR VALIDATED 0001085146-21-003377
2021-06-30 2021-08-16 13F-HR VALIDATED 0001085146-21-002609
2021-03-31 2021-05-14 13F-HR VALIDATED 0001085146-21-001696
2020-12-31 2021-02-16 13F-HR VALIDATED 0001085146-21-000998
2020-09-30 2020-11-13 13F-HR VALIDATED 0001085146-20-002962
2020-06-30 2020-08-17 13F-HR VALIDATED 0001085146-20-002333
2020-03-31 2020-05-15 13F-HR VALIDATED 0001085146-20-001614
2019-12-31 2020-02-13 13F-HR VALIDATED 0001085146-20-000685
2019-09-30 2019-11-14 13F-HR QUARANTINED 0001085146-19-003018
2019-06-30 2019-08-13 13F-HR VALIDATED 0001085146-19-002213
2019-03-31 2019-05-15 13F-HR VALIDATED 0001085146-19-001661
2018-12-31 2019-02-08 13F-HR VALIDATED 0001085146-19-000438
2018-09-30 2018-11-09 13F-HR VALIDATED 0001085146-18-002565
2018-06-30 2018-08-10 13F-HR VALIDATED 0001085146-18-001980
2018-03-31 2018-05-15 13F-HR VALIDATED 0001085146-18-001511
2017-12-31 2018-02-14 13F-HR VALIDATED 0001085146-18-000853
2017-09-30 2017-11-09 13F-HR VALIDATED 0001085146-17-002260
2017-06-30 2017-08-11 13F-HR VALIDATED 0001085146-17-001787
2017-03-31 2017-05-12 13F-HR VALIDATED 0001085146-17-001247
2016-12-31 2017-02-10 13F-HR VALIDATED 0001085146-17-000484
2016-09-30 2016-11-10 13F-HR VALIDATED 0001085146-16-004738
2016-06-30 2016-08-12 13F-HR VALIDATED 0001085146-16-004282
2016-03-31 2016-05-13 13F-HR VALIDATED 0001085146-16-003759
2015-12-31 2016-02-12 13F-HR VALIDATED 0001085146-16-003105
2015-09-30 2015-11-13 13F-HR VALIDATED 0001085146-15-002339
2015-06-30 2015-08-14 13F-HR VALIDATED 0001085146-15-001835
2015-03-31 2015-05-15 13F-HR/A · restatement VALIDATED 0001085146-15-001283
2015-03-31 2015-05-15 13F-HR VALIDATED 0001085146-15-001268
2014-12-31 2015-02-13 13F-HR VALIDATED 0001085146-15-000518
2014-09-30 2014-11-14 13F-HR VALIDATED 0001085146-14-002342
2014-06-30 2014-08-14 13F-HR VALIDATED 0001085146-14-001706
2014-03-31 2014-05-15 13F-HR VALIDATED 0001085146-14-001202
2013-12-31 2014-02-14 13F-HR VALIDATED 0001085146-14-000711
2013-09-30 2013-11-19 13F-HR/A · restatement VALIDATED 0001085146-13-002041
2013-09-30 2013-11-14 13F-HR VALIDATED 0001085146-13-002005
2013-06-30 2013-08-14 13F-HR VALIDATED 0001085146-13-001521
2013-03-31 2013-05-15 13F-HR VALIDATED 0001085146-13-000996
2012-12-31 2013-02-14 13F-HR VALIDATED 0001085146-13-000612
2012-09-30 2012-11-14 13F-HR VALIDATED 0001085146-12-001484
2012-06-30 2012-10-02 13F-HR/A · add new holdings VALIDATED 0001085146-12-001179
2012-06-30 2012-08-14 13F-HR VALIDATED 0001085146-12-001123
2012-03-31 2012-05-15 13F-HR VALIDATED 0001085146-12-000807
2011-12-31 2012-02-14 13F-HR VALIDATED 0001085146-12-000452
2011-09-30 2011-11-14 13F-HR VALIDATED 0001085146-11-001255
2011-06-30 2011-08-15 13F-HR VALIDATED 0001085146-11-000971
2011-03-31 2011-05-16 13F-HR VALIDATED 0001085146-11-000692
2010-12-31 2011-02-11 13F-HR VALIDATED 0001085146-11-000214
2010-09-30 2010-11-19 13F-HR/A · restatement VALIDATED 0001085146-10-001030
2010-09-30 2010-11-15 13F-HR VALIDATED 0001085146-10-000994
2010-06-30 2010-08-16 13F-HR VALIDATED 0001085146-10-000770
2010-03-31 2010-05-17 13F-HR VALIDATED 0001085146-10-000515
2009-12-31 2010-02-22 13F-HR/A · add new holdings VALIDATED 0001085146-10-000301
2009-12-31 2010-02-16 13F-HR VALIDATED 0001085146-10-000266
2009-09-30 2009-11-16 13F-HR VALIDATED 0001085146-09-003520
2009-06-30 2009-08-14 13F-HR VALIDATED 0001085146-09-003248
2009-03-31 2009-05-15 13F-HR VALIDATED 0001085146-09-002259
2008-12-31 2009-02-17 13F-HR VALIDATED 0001085146-09-001134
2008-09-30 2008-11-14 13F-HR QUARANTINED 0001085146-08-001665
2008-06-30 2008-08-14 13F-HR VALIDATED 0001085146-08-001017
2007-12-31 2008-08-14 13F-HR/A · add new holdings VALIDATED 0001085146-08-000976
2007-09-30 2008-08-14 13F-HR/A · add new holdings VALIDATED 0001085146-08-000975
2008-03-31 2008-08-14 13F-HR/A · add new holdings VALIDATED 0001085146-08-000974
2008-03-31 2008-05-14 13F-HR VALIDATED 0001085146-08-000698
2007-12-31 2008-02-14 13F-HR QUARANTINED 0001085146-08-000404
2007-09-30 2007-11-14 13F-HR VALIDATED 0001085146-07-001085
2007-06-30 2007-08-14 13F-HR VALIDATED 0001085146-07-000852
2007-03-31 2007-05-15 13F-HR VALIDATED 0001085146-07-000646
2006-12-31 2007-02-14 13F-HR VALIDATED 0001085146-07-000399
2006-09-30 2006-11-14 13F-HR VALIDATED 0001085146-06-000705
2006-06-30 2006-08-11 13F-HR VALIDATED 0001085146-06-000496
2006-03-31 2006-05-15 13F-HR VALIDATED 0001085146-06-000362
2005-12-31 2006-02-15 13F-HR VALIDATED 0001085146-06-000175
2005-09-30 2005-11-14 13F-HR VALIDATED 0001085146-05-000552
2005-06-30 2005-08-15 13F-HR VALIDATED 0001085146-05-000412
2005-03-31 2005-05-16 13F-HR QUARANTINED 0001085146-05-000273
2004-12-31 2005-02-14 13F-HR VALIDATED 0001085146-05-000109
2004-09-30 2004-11-12 13F-HR VALIDATED 0001085146-04-000440
2004-06-30 2004-08-12 13F-HR VALIDATED 0001085146-04-000307
2004-03-31 2004-05-13 13F-HR VALIDATED 0001085146-04-000225
2003-12-31 2004-02-13 13F-HR QUARANTINED 0001085146-04-000113
2003-09-30 2003-11-14 13F-HR VALIDATED 0001085146-03-000351
2003-06-30 2003-08-13 13F-HR VALIDATED 0001085146-03-000251
2003-03-31 2003-05-08 13F-HR VALIDATED 0001085146-03-000154
2002-12-31 2003-02-14 13F-HR VALIDATED 0001085146-03-000059
2002-09-30 2002-11-13 13F-HR VALIDATED 0001085146-02-000198
2002-06-30 2002-08-14 13F-HR QUARANTINED 0001085146-02-000148
2002-03-31 2002-05-15 13F-HR QUARANTINED 0001085146-02-000093
2001-12-31 2002-02-13 13F-HR QUARANTINED 0001085146-02-000044
2001-09-30 2001-10-31 13F-HR QUARANTINED 0001040273-01-500014
2001-06-30 2001-07-17 13F-HR QUARANTINED 0001040273-01-500011
2001-03-31 2001-05-02 13F-HR QUARANTINED 0001040273-01-500009
2000-12-31 2001-02-08 13F-HR QUARANTINED 0001040273-01-500005
2000-09-30 2000-10-24 13F-HR QUARANTINED 0001040273-00-500014
2000-06-30 2000-07-20 13F-HR/A QUARANTINED 0001040273-00-500008
2000-06-30 2000-07-20 13F-HR QUARANTINED 0001040273-00-500005
Open interactive changes in the app